Microrna-181 Serves As a Dual-Role Regulator in the Development of Human Cancers Publisher Pubmed



Rezaei T^{1, 2} ; Amini M³ ; Hashemi ZS⁴ ; Mansoori B^{3, 5, 6} ; Rezaei S² ; Karami H² ; Mosafer J⁷ ; Mokhtarzadeh A³ ; Baradaran B³ Show Affiliations
Source: Free Radical Biology and Medicine Published:2020

Abstract

MicroRNAs (miRNAs) as the regulatory short noncoding RNAs are involved in a wide array of cellular and molecular processes. They negatively regulate gene expression and their dysfunction is correlated with cancer development through modulation of multiple signaling pathways. Therefore, these molecules could be considered as novel biomarkers and therapeutic targets for more effective management of human cancers. Recent studies have demonstrated that the miR-181 family is dysregulated in various tumor tissues and plays a pivotal role in carcinogenesis. They have been shown to act as oncomirs or tumor suppressors considering their mRNA targets and to be involved in cell proliferation, apoptosis, autophagy, angiogenesis and drug resistance. Additionally, these miRNAs have been demonstrated to exert their regulatory effects through modulating multiple signaling pathways including PI3K/AKT, MAPK, TGF-b, Wnt, NF-κB, Notch pathways. Given that, in this review, we briefly summarise the recent studies that have focused on the roles of miRNA-181 family as the multifunctional miRNAs in tumorigenesis and cancer development. These miRNAs may serve as diagnostic and prognostic biomarkers or therapeutic targets in human cancer gene therapy. © 2019 Elsevier Inc.